FAST NEWS: Hesai Makes Biggest U.S. IPO by Chinese Firm Since 2021
The latest: Light detection and ranging (LiDAR) technology maker Hesai Group (HSAI.US) made its IPO trading debut on Thursday, upping Structure Therapeutics Inc. (GPCR.US), which went public on Feb. 3,…
FAST NEWS: Structure Therapeutics Leaps in U.S. Trading Debut
The latest: Innovative drug developer Structure Therapeutics Inc. (GPCR.US) made its IPO trading debut last Friday, becoming the first major U.S. listing by a Chinese company this year.Looking up: The company…
Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech
The maker of G-protein-coupled receptor (GPCR) drugs will raise more than $100 million in its IPO this week, making it the first major U.S. listing by a Chinese company this…
RELATED ARTICLES
-
Hesai fights ‘capricious’ U.S. Defense Department charges
HSAI.US - RoboSense steers tricky course in self-drive tech market
-
When will profits arrive for RoboSense?
2498.HK
- WeRide merges into crowded field of autonomous driving IPOs
- CHINA BULLETIN: Services, Trade Send Positive Signals
- QCraft revs up its fundraising in autonomous driving race for cash
-
ArriVent wows investors with promising China-developed lung cancer treatment
AVBP.US
